Department of Philosophy, Western University
Cory Goldstein is a doctoral student in philosophy at Western University. He received a B.A. in philosophy from McGill University (2014), and an M.A. in philosophy from Western University (2016). His philosophical interests are primarily in applied ethics, particularly the ethical design and conduct of medical research. He is currently working on two projects exploring the ethical issues of pragmatic randomized controlled trials. He enjoys travelling to and from Tim Horton’s to refuel on coffee, taking long walks on “concrete beach” outside of Western’s University Community Centre, and running from the geese on campus.
My doctoral project explores ethical questions raised by the use of renal dialysis facilities as a research platform for the conduct of pragmatic randomized controlled trials, specifically those that use electronic health records and innovative trial designs. These trials evaluate the adoption of medical treatment—e.g., longer dialysis times, different hemodialysis temperatures, or lower dialysate sodium concentration—as policy at participating dialysis facilities.
Some ethical questions may include the following: Given that the medical treatment in such studies could be evaluated with an individual randomized controlled trial, under what circumstances is the use of an innovative pragmatic design (e.g., stepped-wedge trial, or cluster-crossover trial) appropriate? Do patients and health providers have an ethical obligation to participate in pragmatic randomized controlled trials? From whom, how, and when is informed consent required? How can a waiver of consent be consistent with the notion of respect for persons? Who are the gatekeepers in pragmatic randomized controlled trials, and what are their responsibilities?
Currently, we lack a robust ethical framework for pragmatic randomized controlled trials. As a graduate research assistant, I work with two CIHR-funded research teams whose aim is to produce guidance for the ethical design and conduct of these trials. My doctoral project aims to provide a robust ethical framework to help facilitate the research teams’ overlapping goal.
Goldstein CE, Weijer C, Brehaut JC, Fergusson DA, Grimshaw JM, Horn AR, Taljaard M. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation. BMC Medical Ethics 2018.
Weijer C, Goldstein CE, Taljaard M. TwiC or treat? Are trials within cohorts ethically defensible? Clinical Trials 2018; 5(1): 21-24.
Goldstein CE, Brehaut J, Weijer C. Does consent form follow function? American Journal of Bioethics 2017; 17(12): 29-31.
Campbell MK, Weijer C, Goldstein CE, Edwards SJL. Do doctors have a duty to take part in pragmatic randomised trials? BMJ 2017; 357:j2817.
Peer Reviewed Conference Abstracts:
Goldstein CE, Horn AR, Taljaard M, Weijer C. Ethical issues in individual-cluster trials: beyond the Ottawa Statement. Trials 2017, 18(Suppl 1):200.
Horn AR, Goldstein CE, Taljaard M, Weijer C. “An ethical analysis of the FIRST trial: addressing ethical challenges in pragmatic cluster randomized trials of policy interventions targeting healthcare providers.” Trials 2017, 18(Suppl 1):200.
Goldstein CE, Weijer C. The learning health care system and conscription into research: the content and limits of a Rawlsian common good. Meeting of the American Society for Bioethics and Humanities, Kansas City, US. October 20, 2017.
Goldstein CE, Horn AR, Taljaard M, Weijer C. Ethical issues in individual-cluster trials: beyond the Ottawa Statement. Meeting of the Canadian Bioethics Society, Montreal, Canada. May 17, 2017.
Goldstein CE, Horn AR, Taljaard M, Weijer C. Ethical issues in individual-cluster trials: beyond the Ottawa Statement. International Clinical Trials and Methodology Conference and meeting of the Society for Clinical Trials, Liverpool, UK. May 9, 2017.
Goldstein CE, Taljaard M, Weijer C.“Ethics of pragmatic randomized controlled trials. Meeting of the Society for Clinical Trials, Montreal, Canada. May 17, 2016.
Goldstein CE, Horn AR, Taljaard M, Weijer C. Ethical issues in individual-cluster trials: beyond the Ottawa Statement. Ethox Centre, Oxford, UK. May 10, 2017.
Eldridge S, Grimshaw JM, Goldstein CE, Hey SP, Weijer C. The pragmatic randomized controlled trial at 50: past successes; future challenges (Invited panel). International Clinical Trials and Methodology Conference and meeting of the Society for Clinical Trials, Liverpool, UK. May 9, 2017.
Media and Outreach:
Fice N, Goldstein CE, Horn AR. Forgotten role of reproductive justice in Zika crisis addressed. Western News. January 26, 2017.
Goldstein CE, Horn AR. Navigating ethical dilemmas in healthcare: interview with Kyoko Wada. Rotman Institute of Philosophy Blog. November 24, 2016.
Fice N, Goldstein CE, Horn AR. (2016). Zika: an epidemic or an issue of reproductive justice? Western News. November 22, 2016.
Goldstein CE. (2016). Avoiding the ‘slippery slope’ in crafting physician-assisted death legislation. Western News. April 14, 2016.
Goldstein CE. (2016). Physician assisted death: challenges for social policy in Canada. Rotman Institute of Philosophy Blog. April 5, 2016.
Project Title: Developing a framework for the ethical design and conduct of pragmatic randomized controlled trials to improve the quality and value of health care systems and practices
Principal Investigators: Monica Taljaard, Dean Fergusson, Terry Klassen, Charles Weijer
Brief Description: Pragmatic randomized controlled trials (RCTs) can provide patients, doctors and policymakers with more reliable information as to which treatments and strategies are best for patients. But whilst ethical guidelines exist to protect participants in research, their applicability for pragmatic RCTs is not straightforward. This has led to confusion, where some trials have been carried out with inadequate protections, and in others, strict enforcement of current guidelines have posed unnecessary obstacles, undermining scientific quality and impeding improvements in the quality of healthcare. Our goal is to develop internationally accepted guidance for the ethical design and conduct of pragmatic RCTs.
Project Title: An integrated platform for innovative pragmatic cluster-randomized registry trials in hemodialysis
Principal Investigators: Amit Garg, Monica Taljaard, Charles Weijer
Brief Description: Hemodialysis is a life-sustaining treatment for patients whose kidneys have failed. However, quality of life is poor (worse than many advanced cancers), life expectancy is short (average three years), and associated healthcare costs are high (~$10,800 per patient per month). Our goal is to improve the experiences, outcomes, and healthcare of patients receiving hemodialysis. We will do this by leveraging our partnerships to bring together expertise and health data assets onto an integrated platform to conduct innovative pragmatic registry trials in hemodialysis, and to translate these comparative-effectiveness trials into better practice. We plan to embed large pragmatic randomized trials into routine hemodialysis care and make use of existing data-rich registries with linked healthcare data for almost all baseline and follow-up information. We can complete trials with the same quality and statistical power as the traditional approach, in less time and a lower per-patient cost.
Phil 2715G: Health Care Ethics (Lead T.A.) – Prof. C. Weijer, W2017
Phil 3993F: The Ethics of Science – Prof. G. Barker F2016
Phil 2715G: Health Care Ethics – Prof. C. Weijer, W2016
Phil 2400F: Intro to Philosophy of Mind – Prof. C. Viger, F2015
“Informed consent” (September 2017). Phil 3730F Research Ethics, Department of Philosophy, Western University (Prof. C. Weijer).
“Ethical theory in public health policy” (March 2017). MPH 9009B Health Policy, Law & Equity, Schulich Interfaculty Program in Public Health, Schulich School of Medicine & Dentistry, Western University (Prof. J Shelley).
“Clinical equipoise” (October 2016). Phil 4996F Research Ethics, Department of Philosophy, Western University (Prof. C Weijer).